What it sells
Maximum information per experiment, minimum experiments per conclusion
Business model breakdown
Buyer: who owns the budget?
UnverifiedR&D scientists and research leads in biotech and bioengineering.
Trigger: what makes them buy now?
Experiments are costly and poorly chosen; knowledge scattered, results do not reproduce.
Workflow: what inputs become what output?
Simulate each possible experiment outcome with several models and methods, surface every assumption, and recommend the experimental design that most reduces uncertainty.
Distribution: how it reaches customers
Waitlist and log-in; early-access product.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Fall 2026 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.